">
(August 2014) The Kenya AIDS Indicator Survey (KAIS) 2012 was the first national population-based survey in Kenya to collect HIV information for children ages 18 months to 14 years in order to estimate the number of children living with HIV, as well as the need for HIV care and treatment. KAIS 2012 also interviewed children ages 10 to 14 to gather information about HIV knowledge, attitudes, and risk behaviors among this adolescent population. The information presented in this data sheet is based on parent’s report for the 18 months to 14 years age group and on the child’s interview for the 10-to-14 years age group.
The prevalence of HIV among children ages 18 months to 14 years was 0.9 percent. This corresponds to an estimated 101,000 children infected with HIV in the country. The prevalence of HIV was 1.1 percent for females and 0.7 percent for males in this age group.
KAIS 2012 was supported by National AIDS and STI Control Programme (NASCOP), Kenya National Bureau of Statistics (KNBS), National Public Health Laboratory Services (NPHLS), National AIDS Control Council (NACC), National Council for Population and Development (NCPD), Kenya Medical Research Institute (KEMRI), U.S. Centers for Disease Control and Prevention (CDC/Kenya, CDC/Atlanta), United States Agency for International Development (USAID/Kenya), University of California, San Francisco (UCSF), Joint United Nations Team on HIV/AIDS, Japan International Cooperation Agency (JICA), Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Liverpool Voluntary Counselling and Testing (LVCT), African Medical and Research Foundation (AMREF), World Bank, and Global Fund. The development of the KAIS 2012 wall chart was supported by the National Council for Population and Development (NCPD) and the Population Reference Bureau (PRB) with support from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through Cooperative Agreement AID-0AA-A-10-00009 through USAID.
KAIS 2012 was made possible by support from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through cooperative agreements [#PS001805, GH000069, and PS001814] through the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA). This survey was also funded in part by support from the Global Fund, World Bank, and the Joint United Nations Team for HIV/AIDS.